CG-001

N/A

Report date: 2026/05/08 20:02:52

Base Information

Drug NameCG-001
Drug Alias NameCG-001
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionComplement C3 inhibitors
TargetsComplement C3
Therapy Area/IndicationsAutoimmune DiseasesHemoglobinuria, ParoxysmalMyasthenia Gravis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesChengdu Konjin Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesShanghai Kangjing Biomedical Technology Co LtdChengdu Konjin Co Ltd
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesHemoglobinuria, ParoxysmalMyasthenia Gravis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A